CAPN12 Antikörper (PE)
Kurzübersicht für CAPN12 Antikörper (PE) (ABIN2172218)
Target
Alle CAPN12 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Calpain 12
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Exitation/Emission: 480,565nm/578nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months.
-
-
- CAPN12 (Calpain 12 (CAPN12))
-
Andere Bezeichnung
- Calpain 12
-
Hintergrund
-
Calpains are a family of cytosolic calcium activated cysteine proteases involved in a variety of cellular processes including apoptosis, cell division, modulation of integrin and cytoskeletal interactions, and synaptic plasticity. Calpain 12 was first described in the mouse, most strongly in the skin, and maps to mouse chromosome 7. Isoforms differ in the carboxyterminal ends, ending with aberrant domain III and lacking domain IV. Domains in the large subunit include the amino terminal domain I, the proteinase domain II, domain III, and the EF hand domain IV, making Calpain 12 most similar to calpains 1 and 2.
Synonyms: Calpain12, Calpain-12, CAPN 12, CAPN12, EC 3.4.22., MGC20576, CAN12_HUMAN. -
Gen-ID
- 147968
Target
-